Keyphrases
Cystic Fibrosis
100%
Ivacaftor
100%
CFTR mutations
100%
Double-blind Randomized Controlled Trial
100%
Forced Expiratory Volume in 1 Second (FEV1)
46%
Placebo
33%
Sweat Chloride
20%
Cystic Fibrosis Questionnaire-Revised
20%
Absolute Change
20%
Treatment Difference
20%
Domain Scores
13%
Open-label Extension
13%
Placebo-controlled
6%
Adult Patients
6%
Randomized Placebo-controlled Trial
6%
Lung Function
6%
Safety Concerns
6%
Double-blind Randomized Clinical Trial
6%
Interim Analysis
6%
Difference in Mean
6%
Subgroup Analysis
6%
Change from Baseline
6%
Residual Function
6%
Score Function
6%
Gating mutation
6%
Medicine and Dentistry
Patient with Cystic Fibrosis
100%
Ivacaftor
100%
Randomized Controlled Trial
100%
Placebo
40%
Cystic Fibrosis
20%
Sweat
20%
Diseases
6%
Forced Expiratory Volume
6%
Randomized Clinical Trial
6%
Placebo-Controlled Study
6%
Subgroup Analysis
6%
Interim Analysis
6%
Lung
6%